| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OCULAR THERAPEUTIX, INC | Director | Common Stock | 50,000 | $372,500 | $7.45 | 11 Jun 2025 | Direct |
| Opus Genetics, Inc. | Director | Common Stock | 103,147 | $234,143 | $2.27 | 01 Jan 2026 | Direct |
| Opus Genetics, Inc. | Director | Stock Option (Right to Buy) | 79,592 | 30 Apr 2025 | Direct | ||
| OCULAR THERAPEUTIX, INC | Director | Stock Option (Right to Buy) | 44,000 | 11 Jun 2025 | Direct | ||
| HARROW, INC. | Director | RSU | 7,339 | 20 Jun 2025 | Direct | ||
| IVERIC bio, Inc. | Director | Common Stock | 0 | $39.45 | 11 Jul 2023 | Direct | |
| IVERIC bio, Inc. | Director | Restricted Stock Units | 0 | 11 Jul 2023 | Direct | ||
| IVERIC bio, Inc. | Director | Stock Option (Right to Buy) | 0 | $10.03 | 11 Jul 2023 | Direct |